Copyright Reports & Markets. All rights reserved.

Global Therapeutic Radiopharmaceuticals Sales Market Report 2021

Request for Sample of this report
Buy now

1 Therapeutic Radiopharmaceuticals Market Overview

  • 1.1 Therapeutic Radiopharmaceuticals Product Scope
  • 1.2 Therapeutic Radiopharmaceuticals Segment by Type
    • 1.2.1 Global Therapeutic Radiopharmaceuticals Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Radium-223
    • 1.2.3 Lutetium-177
    • 1.2.4 Iodine-131
    • 1.2.5 Other
  • 1.3 Therapeutic Radiopharmaceuticals Segment by Application
    • 1.3.1 Global Therapeutic Radiopharmaceuticals Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Thyroid
    • 1.3.3 Bone Metastasis
    • 1.3.4 Lymphoma
    • 1.3.5 Other
  • 1.4 Therapeutic Radiopharmaceuticals Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Therapeutic Radiopharmaceuticals Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Therapeutic Radiopharmaceuticals Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Therapeutic Radiopharmaceuticals Price Trends (2016-2027)

2 Therapeutic Radiopharmaceuticals Estimates and Forecasts by Region

  • 2.1 Global Therapeutic Radiopharmaceuticals Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Therapeutic Radiopharmaceuticals Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Therapeutic Radiopharmaceuticals Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
  • 2.3 Global Therapeutic Radiopharmaceuticals Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Therapeutic Radiopharmaceuticals Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Therapeutic Radiopharmaceuticals Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Therapeutic Radiopharmaceuticals Estimates and Projections (2016-2027)
    • 2.4.2 Europe Therapeutic Radiopharmaceuticals Estimates and Projections (2016-2027)
    • 2.4.3 China Therapeutic Radiopharmaceuticals Estimates and Projections (2016-2027)
    • 2.4.4 Japan Therapeutic Radiopharmaceuticals Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Therapeutic Radiopharmaceuticals Estimates and Projections (2016-2027)
    • 2.4.6 India Therapeutic Radiopharmaceuticals Estimates and Projections (2016-2027)

3 Global Therapeutic Radiopharmaceuticals Competition Landscape by Players

  • 3.1 Global Top Therapeutic Radiopharmaceuticals Players by Sales (2016-2021)
  • 3.2 Global Top Therapeutic Radiopharmaceuticals Players by Revenue (2016-2021)
  • 3.3 Global Therapeutic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Radiopharmaceuticals as of 2020)
  • 3.4 Global Therapeutic Radiopharmaceuticals Average Price by Company (2016-2021)
  • 3.5 Manufacturers Therapeutic Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Therapeutic Radiopharmaceuticals Market Size by Type

  • 4.1 Global Therapeutic Radiopharmaceuticals Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Therapeutic Radiopharmaceuticals Price by Type (2016-2021)
  • 4.2 Global Therapeutic Radiopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Therapeutic Radiopharmaceuticals Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Therapeutic Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Therapeutic Radiopharmaceuticals Price Forecast by Type (2022-2027)

5 Global Therapeutic Radiopharmaceuticals Market Size by Application

  • 5.1 Global Therapeutic Radiopharmaceuticals Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Therapeutic Radiopharmaceuticals Price by Application (2016-2021)
  • 5.2 Global Therapeutic Radiopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Therapeutic Radiopharmaceuticals Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Therapeutic Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Therapeutic Radiopharmaceuticals Price Forecast by Application (2022-2027)

6 North America Therapeutic Radiopharmaceuticals Market Facts & Figures

  • 6.1 North America Therapeutic Radiopharmaceuticals Sales by Company
    • 6.1.1 North America Therapeutic Radiopharmaceuticals Sales by Company (2016-2021)
    • 6.1.2 North America Therapeutic Radiopharmaceuticals Revenue by Company (2016-2021)
  • 6.2 North America Therapeutic Radiopharmaceuticals Sales Breakdown by Type
    • 6.2.1 North America Therapeutic Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Therapeutic Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
  • 6.3 North America Therapeutic Radiopharmaceuticals Sales Breakdown by Application
    • 6.3.1 North America Therapeutic Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Therapeutic Radiopharmaceuticals Sales Breakdown by Application (2022-2027)

7 Europe Therapeutic Radiopharmaceuticals Market Facts & Figures

  • 7.1 Europe Therapeutic Radiopharmaceuticals Sales by Company
    • 7.1.1 Europe Therapeutic Radiopharmaceuticals Sales by Company (2016-2021)
    • 7.1.2 Europe Therapeutic Radiopharmaceuticals Revenue by Company (2016-2021)
  • 7.2 Europe Therapeutic Radiopharmaceuticals Sales Breakdown by Type
    • 7.2.1 Europe Therapeutic Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Therapeutic Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Therapeutic Radiopharmaceuticals Sales Breakdown by Application
    • 7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)

8 China Therapeutic Radiopharmaceuticals Market Facts & Figures

  • 8.1 China Therapeutic Radiopharmaceuticals Sales by Company
    • 8.1.1 China Therapeutic Radiopharmaceuticals Sales by Company (2016-2021)
    • 8.1.2 China Therapeutic Radiopharmaceuticals Revenue by Company (2016-2021)
  • 8.2 China Therapeutic Radiopharmaceuticals Sales Breakdown by Type
    • 8.2.1 China Therapeutic Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Therapeutic Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
  • 8.3 China Therapeutic Radiopharmaceuticals Sales Breakdown by Application
    • 8.3.1 China 315 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 315 Sales Breakdown by Application (2022-2027)

9 Japan Therapeutic Radiopharmaceuticals Market Facts & Figures

  • 9.1 Japan Therapeutic Radiopharmaceuticals Sales by Company
    • 9.1.1 Japan Therapeutic Radiopharmaceuticals Sales by Company (2016-2021)
    • 9.1.2 Japan Therapeutic Radiopharmaceuticals Revenue by Company (2016-2021)
  • 9.2 Japan Therapeutic Radiopharmaceuticals Sales Breakdown by Type
    • 9.2.1 Japan Therapeutic Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Therapeutic Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Therapeutic Radiopharmaceuticals Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Therapeutic Radiopharmaceuticals Market Facts & Figures

  • 10.1 Southeast Asia Therapeutic Radiopharmaceuticals Sales by Company
    • 10.1.1 Southeast Asia Therapeutic Radiopharmaceuticals Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Therapeutic Radiopharmaceuticals Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Therapeutic Radiopharmaceuticals Sales Breakdown by Type
    • 10.2.1 Southeast Asia Therapeutic Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Therapeutic Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Therapeutic Radiopharmaceuticals Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Therapeutic Radiopharmaceuticals Market Facts & Figures

  • 11.1 India Therapeutic Radiopharmaceuticals Sales by Company
    • 11.1.1 India Therapeutic Radiopharmaceuticals Sales by Company (2016-2021)
    • 11.1.2 India Therapeutic Radiopharmaceuticals Revenue by Company (2016-2021)
  • 11.2 India Therapeutic Radiopharmaceuticals Sales Breakdown by Type
    • 11.2.1 India Therapeutic Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Therapeutic Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
  • 11.3 India Therapeutic Radiopharmaceuticals Sales Breakdown by Application
    • 11.3.1 India Therapeutic Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Therapeutic Radiopharmaceuticals Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Therapeutic Radiopharmaceuticals Business

  • 12.1 Bayer
    • 12.1.1 Bayer Corporation Information
    • 12.1.2 Bayer Business Overview
    • 12.1.3 Bayer Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Bayer Therapeutic Radiopharmaceuticals Products Offered
    • 12.1.5 Bayer Recent Development
  • 12.2 Novartis
    • 12.2.1 Novartis Corporation Information
    • 12.2.2 Novartis Business Overview
    • 12.2.3 Novartis Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Novartis Therapeutic Radiopharmaceuticals Products Offered
    • 12.2.5 Novartis Recent Development
  • 12.3 China Isotope & Radiation
    • 12.3.1 China Isotope & Radiation Corporation Information
    • 12.3.2 China Isotope & Radiation Business Overview
    • 12.3.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 China Isotope & Radiation Therapeutic Radiopharmaceuticals Products Offered
    • 12.3.5 China Isotope & Radiation Recent Development
  • 12.4 Dongcheng
    • 12.4.1 Dongcheng Corporation Information
    • 12.4.2 Dongcheng Business Overview
    • 12.4.3 Dongcheng Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Dongcheng Therapeutic Radiopharmaceuticals Products Offered
    • 12.4.5 Dongcheng Recent Development
  • 12.5 Q BioMed
    • 12.5.1 Q BioMed Corporation Information
    • 12.5.2 Q BioMed Business Overview
    • 12.5.3 Q BioMed Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Q BioMed Therapeutic Radiopharmaceuticals Products Offered
    • 12.5.5 Q BioMed Recent Development
  • 12.6 Curium Pharmaceuticals
    • 12.6.1 Curium Pharmaceuticals Corporation Information
    • 12.6.2 Curium Pharmaceuticals Business Overview
    • 12.6.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Products Offered
    • 12.6.5 Curium Pharmaceuticals Recent Development
  • 12.7 Jubilant DraxImage
    • 12.7.1 Jubilant DraxImage Corporation Information
    • 12.7.2 Jubilant DraxImage Business Overview
    • 12.7.3 Jubilant DraxImage Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Jubilant DraxImage Therapeutic Radiopharmaceuticals Products Offered
    • 12.7.5 Jubilant DraxImage Recent Development
  • 12.8 Lantheus
    • 12.8.1 Lantheus Corporation Information
    • 12.8.2 Lantheus Business Overview
    • 12.8.3 Lantheus Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Lantheus Therapeutic Radiopharmaceuticals Products Offered
    • 12.8.5 Lantheus Recent Development
  • 12.9 Spectrum Pharmaceuticals
    • 12.9.1 Spectrum Pharmaceuticals Corporation Information
    • 12.9.2 Spectrum Pharmaceuticals Business Overview
    • 12.9.3 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Products Offered
    • 12.9.5 Spectrum Pharmaceuticals Recent Development
  • 12.10 Progenics Pharmaceuticals
    • 12.10.1 Progenics Pharmaceuticals Corporation Information
    • 12.10.2 Progenics Pharmaceuticals Business Overview
    • 12.10.3 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Products Offered
    • 12.10.5 Progenics Pharmaceuticals Recent Development
  • 12.11 International Isotopes
    • 12.11.1 International Isotopes Corporation Information
    • 12.11.2 International Isotopes Business Overview
    • 12.11.3 International Isotopes Therapeutic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 International Isotopes Therapeutic Radiopharmaceuticals Products Offered
    • 12.11.5 International Isotopes Recent Development

13 Therapeutic Radiopharmaceuticals Manufacturing Cost Analysis

  • 13.1 Therapeutic Radiopharmaceuticals Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Therapeutic Radiopharmaceuticals
  • 13.4 Therapeutic Radiopharmaceuticals Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Therapeutic Radiopharmaceuticals Distributors List
  • 14.3 Therapeutic Radiopharmaceuticals Customers

15 Market Dynamics

  • 15.1 Therapeutic Radiopharmaceuticals Market Trends
  • 15.2 Therapeutic Radiopharmaceuticals Drivers
  • 15.3 Therapeutic Radiopharmaceuticals Market Challenges
  • 15.4 Therapeutic Radiopharmaceuticals Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Therapeutic Radiopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Radium-223
    Lutetium-177
    Iodine-131
    Other

    Segment by Application
    Thyroid
    Bone Metastasis
    Lymphoma
    Other

    The Therapeutic Radiopharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the Therapeutic Radiopharmaceuticals market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Bayer
    Novartis
    China Isotope & Radiation
    Dongcheng
    Q BioMed
    Curium Pharmaceuticals
    Jubilant DraxImage
    Lantheus
    Spectrum Pharmaceuticals
    Progenics Pharmaceuticals
    International Isotopes

    Buy now